Blog
In-depth breakdowns of every GLP-1 medication on the market, including dosing schedules, side effects, and head-to-head comparisons.
One of the open problems with GLP-1 weight loss is that you lose muscle along with the fat. Three biologics in late-stage development are designed specifically to solve that problem. They will likely change how GLP-1 prescriptions are written.
MedicationsThe full Mounjaro dose escalation schedule from 2.5mg to 15mg, including what each pen contains, injection timing, missed dose protocols, and what to expect at every step.
MedicationsWhat tirzepatide weight loss actually looks like month by month, based on clinical trial data and real patient outcomes. Realistic expectations at every dose level.
MedicationsThe complete semaglutide dosage chart for weight loss including Wegovy, Ozempic, compounded semaglutide, and oral Rybelsus. Dose escalation schedules, unit conversions, and what to do at each stage.
Ozempic can interact with insulin, blood thinners, oral contraceptives, thyroid medications, and more. Here is a complete guide to drug interactions, how delayed gastric emptying affects absorption, and what to tell your provider.
Zepbound has been on the market since late 2023. Here is what real patients report about weight loss results, side effects, costs, and whether they would recommend it, based on thousands of reviews.
MedicationsGLP-1 medications like semaglutide and tirzepatide are showing real cardiovascular benefits in major clinical trials. We break down what SELECT, SOUL, and SURPASS-CVOT actually found, and what it means for heart health.
MedicationsAn evidence-based comparison of every FDA-approved GLP-1 medication for weight loss, with head-to-head trial data, real-world outcomes, and guidance on choosing the right option with your provider.
An objective comparison of compounded semaglutide and FDA-approved Wegovy, covering regulatory status, safety, efficacy, cost, and the evolving FDA position on GLP-1 compounding.
Hit a weight loss plateau on Ozempic? You're not alone. Learn why it happens, when it's normal, and 7 evidence-based strategies to restart your progress.
MedicationsEverything known about retatrutide, the triple-agonist weight loss drug in late-stage clinical trials, including Phase 2 data showing up to 24% weight loss, how it compares to semaglutide and tirzepatide, and when it might be available.
